Literature DB >> 23318919

Opioid dose and risk of road trauma in Canada: a population-based study.

Tara Gomes1, Donald A Redelmeier, David N Juurlink, Irfan A Dhalla, Ximena Camacho, Muhammad M Mamdani.   

Abstract

BACKGROUND: Use of opioids may predispose drivers to road trauma, yet the effect of opioid dose on this association is unknown.
METHODS: We conducted a population-based nested case-control study of patients aged 18 to 64 years who received at least 1 publicly funded prescription for an opioid from April 1, 2003, through March 31, 2011. Cases were defined as having an emergency department visit related to road trauma. Patients without road trauma served as a control group matched to cases by age, sex, index year, prior road trauma, and a disease risk index. We compared the risk of road trauma among patients treated with doses of opioids ranging from very low to very high (<20 to ≥200 morphine equivalents daily). In a subgroup analysis, we stratified our analysis by driver status.
RESULTS: Among 549 878 eligible adults, we identified 5300 cases with road trauma and matched an equal number of controls. Multivariate adjustment yielded no significant association between escalating opioid dose and odds of road trauma (adjusted odds ratio ranged between 1.00 and 1.09). However, a significant association between opioid dose and road trauma was observed among drivers. Compared with very low opioid doses, drivers prescribed low doses had a 21% increased odds of road trauma (adjusted odds ratio, 1.21 [95% CI, 1.02-1.42]); those prescribed moderate doses, 29% increased odds (1.29 [1.06-1.57]); those prescribed high doses, 42% increased odds (1.42 [1.15-1.76]); and those prescribed very high doses, 23% increased odds (1.23 [1.02-1.49]).
CONCLUSIONS: Among drivers prescribed opioids, a significant relationship exists between drug dose and risk of road trauma. This association is distinct and does not appear with passengers, pedestrians, and others injured in road trauma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23318919     DOI: 10.1001/2013.jamainternmed.733

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  49 in total

1.  American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.

Authors:  Amanda M Brandow; C Patrick Carroll; Susan Creary; Ronisha Edwards-Elliott; Jeffrey Glassberg; Robert W Hurley; Abdullah Kutlar; Mohamed Seisa; Jennifer Stinson; John J Strouse; Fouza Yusuf; William Zempsky; Eddy Lang
Journal:  Blood Adv       Date:  2020-06-23

2.  Re-assessing the Validity of the Opioid Risk Tool in a Tertiary Academic Pain Management Center Population.

Authors:  Meredith R Clark; Robert W Hurley; Meredith C B Adams
Journal:  Pain Med       Date:  2018-07-01       Impact factor: 3.750

Review 3.  Opioids for low back pain.

Authors:  Richard A Deyo; Michael Von Korff; David Duhrkoop
Journal:  BMJ       Date:  2015-01-05

4.  Influence of central nervous system-acting drugs on results of cognitive testing in geriatric inpatients.

Authors:  M Gogol; H Hartmann; S Wustmann; A Simm
Journal:  Z Gerontol Geriatr       Date:  2014-06       Impact factor: 1.281

5.  Trends in high-dose opioid prescribing in Canada.

Authors:  Tara Gomes; Muhammad M Mamdani; J Michael Paterson; Irfan A Dhalla; David N Juurlink
Journal:  Can Fam Physician       Date:  2014-09       Impact factor: 3.275

6.  Evaluation of opioid discontinuation after non-orthopaedic surgery among chronic opioid users: a population-based cohort study.

Authors:  Naheed K Jivraj; Damon C Scales; Tara Gomes; Jennifer Bethell; Andrea Hill; Ruxandra Pinto; Duminda N Wijeysundera; Hannah Wunsch
Journal:  Br J Anaesth       Date:  2020-01-27       Impact factor: 9.166

7.  Prescription opioid use among disabled Medicare beneficiaries: intensity, trends, and regional variation.

Authors:  Nancy E Morden; Jeffrey C Munson; Carrie H Colla; Jonathan S Skinner; Julie P W Bynum; Weiping Zhou; Ellen Meara
Journal:  Med Care       Date:  2014-09       Impact factor: 2.983

8.  Exploring substance use and impaired driving among adults aged 21 years and older in the United States, 2015.

Authors:  Amy Jewett; Alexis B Peterson; Erin K Sauber-Schatz
Journal:  Traffic Inj Prev       Date:  2018-11-09       Impact factor: 1.491

9.  [Driving ability with alcohol and drug dependence and schizophrenia].

Authors:  M Soyka; S Dittert; S Kagerer-Volk; M Soyka
Journal:  Nervenarzt       Date:  2014-07       Impact factor: 1.214

10.  Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV.

Authors:  William C Becker; Kirsha Gordon; E Jennifer Edelman; Robert D Kerns; Stephen Crystal; James D Dziura; Lynn E Fiellin; Adam J Gordon; Joseph L Goulet; Amy C Justice; David A Fiellin
Journal:  AIDS Behav       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.